CONSHOHOCKEN, PA — Suvoda is expanding artificial intelligence and integrated workflow capabilities across its clinical-trial technology platform, reporting that its agentic randomization and trial-supply technology can reduce study setup timelines by as much as 80% as the company combines previously separate trial functions.
The release builds on Suvoda’s integration of its technology with Greenphire products, bringing eight clinical-trial functions under a common platform and data layer.
Those functions include randomization and trial supply management, or RTSM/IRT; electronic clinical outcome assessments; electronic consent; scheduling; patient payments; travel; site payments; and budgeting and benchmarking.
Suvoda is introducing AI first across RTSM and electronic clinical outcome assessments, with plans to extend the technology into financial services such as patient payments.
Its agentic RTSM capability has demonstrated reductions of as much as 80% in the time from project kickoff to user acceptance testing, according to the company. The technology automates portions of the setup process while retaining human approval authority.
Suvoda is also deploying Sofia, a conversational AI assistant that allows authorized sponsors and clinical sites to retrieve information and take permitted actions in multiple languages. Actions taken through the system are logged for auditing.
The company’s Product Launchpad is being rolled out across global clinical trials, giving study teams a single login for the eight connected products rather than requiring users to move among separate systems.
A shared data layer allows participant information entered into the RTSM system to flow into other products, reducing duplicate data entry across trial operations.
Suvoda is also adding self-service reporting for sponsors and contract research organizations. A finance and travel portal provides direct access to study data, while its budgeting and benchmarking system now supports negotiations within the platform.
Payment information can feed back into the system’s fair-market-value benchmarks, allowing those benchmarks to incorporate current transaction data.
The changes also extend to patient-facing trial functions. Suvoda’s mobile application allows participants to track visits, arrange transportation, complete questionnaires and receive micropayments for completed tasks.
Clinical sites can conduct video calls for remote visits and provide appointment availability through the platform. Patient reimbursements can be delivered through multiple payment methods, including digital wallets and Alipay in China.
“Sites can spend less time reconciling systems, patients can have an easier clinical trial experience wherever they are, and sponsors get faster answers to their important questions,” Suvoda Chief Executive Officer Jagath Wanninayake said.
The expanded platform reflects Suvoda’s effort to consolidate clinical-trial functions that have traditionally been handled through multiple vendors, systems and support teams, while using automation to reduce manual work across study operations.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.